Diebold Nixdorf (DBD) Stock Forecast, Price & News

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Diebold Nixdorf in the last twelve months. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" DBD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in DBD, but not buy additional shares or sell existing shares.
View DBD analyst ratings or view top-rated stocks.

3 brokerages have issued 1-year price targets for Diebold Nixdorf's stock. Their DBD share price forecasts range from $3.00 to $5.00. On average, they expect the company's stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 1,500.0% from the stock's current price.
View analysts price targets for DBD or view top-rated stocks among Wall Street analysts.

Diebold Nixdorf's stock was trading at $1.42 at the beginning of the year. Since then, DBD shares have decreased by 82.4% and is now trading at $0.25.
View the best growth stocks for 2023 here.

Diebold Nixdorf saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 16,820,000 shares, an increase of 6.9% from the April 15th total of 15,740,000 shares. Based on an average daily volume of 3,710,000 shares, the short-interest ratio is presently 4.5 days. Currently, 22.3% of the company's shares are sold short.
View Diebold Nixdorf's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our DBD earnings forecast.

Diebold Nixdorf, Incorporated (NYSE:DBD) posted its earnings results on Thursday, October, 28th. The technology company reported $0.34 EPS for the quarter, missing the consensus estimate of $0.52 by $0.18. The technology company earned $958.20 million during the quarter, compared to analysts' expectations of $1.04 billion. Diebold Nixdorf had a negative net margin of 14.60% and a negative trailing twelve-month return on equity of 1.43%. The firm's revenue was down 3.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.28 earnings per share.

Diebold Nixdorf issued an update on its FY 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $3.70 billion-$3.90 billion, compared to the consensus revenue estimate of $3.82 billion.

175 employees have rated Diebold Nixdorf Chief Executive Officer Gerrard B. Schmid on Glassdoor.com. Gerrard B. Schmid has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Diebold Nixdorf investors own include AbbVie (ABBV), Chicago Bridge Iron (CBI), Bristol-Myers Squibb (BMY), KKR & Co. Inc. (KKR), Philip Morris International (PM), Vector Group (VGR), Johnson Controls International (JCI), Mattel (MAT), Mondelez International (MDLZ) and Dunkin' Brands Group (DNKN).

Diebold Nixdorf trades on the New York Stock Exchange (NYSE) under the ticker symbol "DBD."

Diebold Nixdorf's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (5.57%), Prescott Group Capital Management L.L.C. (4.50%), Sapience Investments LLC (4.44%), Gamco Investors INC. ET AL (2.86%), Renaissance Technologies LLC (1.89%) and Geode Capital Management LLC (1.73%). Insiders that own company stock include Bruce H Besanko, Gary G Greenfield, Gerrard Schmid, Jeffrey L Rutherford, Jonathan Leiken, Lauren States, Matthew Goldfarb, Octavio Marquez and Phillip R Cox.
View institutional ownership trends.

Shares of DBD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DBD stock can currently be purchased for approximately $0.25.

Diebold Nixdorf (NYSE:DBD) has a market capitalization of $19.90 million and generates $3.46 billion in revenue each year. The technology company earns $-581,400,000.00 in net income (profit) each year or ($6.47) on an earnings per share basis.

The company employs 21,000 workers across the globe.

Diebold Nixdorf's mailing address is 5995 MAYFAIR RD P.O. BOX 3077, NORTH CANTON OH, 44720. The official website for the company is www.dieboldnixdorf.com. The technology company can be reached via phone at (330) 490-4000, via email at steve.virostek@dieboldnixdorf.com, or via fax at 330-490-3794.